Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Digit. Health

Sec. Digital Mental Health

This article is part of the Research TopicGenetic and Immunological Insights into Angioedema Without WhealsView all 12 articles

Ecological Momentary Assessments for Patients with Hereditary Angioedema: A Feasibility and Acceptability Controlled Study

Provisionally accepted
Monica  ParatiMonica Parati1Luca  RanucciLuca Ranucci1Azzurra  CesoniAzzurra Cesoni1Lorenza  Chiara ZingaleLorenza Chiara Zingale1Beatrice  De MariaBeatrice De Maria1Clara  GinoClara Gino1Aida  ZuluetaAida Zulueta1Riccardo  SideriRiccardo Sideri1Alessandra  GoriniAlessandra Gorini1,2*Francesca  PeregoFrancesca Perego1
  • 1Istituti Clinici Scientifici Maugeri SpA IRCCS Milano, Milan, Italy
  • 2Dipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milano, Italia., University of Milan, Milan, Italy, Italy

The final, formatted version of the article will be published soon.

Introduction: Hereditary angioedema (HAE) is a rare disease imposing a significant quality of life burden. Affect monitoring via Ecological Momentary Assessment (EMA) could offer personalized psychological support by collecting repeated, ecological data in real-life, overcoming the limitations of traditional methods. This study assessed the feasibility and acceptability of an EMA protocol for affect monitoring in HAE patients versus healthy controls (CTR). Methods: HAE patients and CTR were recruited for a 16-week EMA study. Participants received weekly EMA surveys assessing affect via REDCap™. Feasibility was evaluated through recruitment, response, and completion rates. Acceptability was assessed via a post-study questionnaire through a visual analogue scale ranging from 1 to 100. Results: Twenty-eight Caucasian subjects were contacted, 12 HAE (median age: 50 [22] years, 5 males) and 14 CTR (age: 30 [32] years, 6 males) agreed to participate, resulting in a recruitment rate of 93%. Response and completion rates were ≥92% and ≥96% respectively in both groups. Completion time was brief and did not differ between groups (HAE: 1' 28'' [29''] vs CTR: 1' 15' [15''], P=0.274). The protocol was considered acceptable by both groups (HAE: rate 83.5 [18.8] vs CTR: 72.0 [13.0], p=0.27) with HAE rating the experience as helpful (79 [39.8]) and thought-provoking (67 [33]). Conclusion: EMA is a highly feasible and acceptable method for affect monitoring in HAE. The presence of a rare disease does not appear to be a barrier to its application, supporting its use in this clinical setting.

Keywords: Ecological Momentary Assessment, hereditary angioedema, Rare Diseases, feasibility, Acceptability

Received: 27 Aug 2025; Accepted: 15 Dec 2025.

Copyright: © 2025 Parati, Ranucci, Cesoni, Zingale, De Maria, Gino, Zulueta, Sideri, Gorini and Perego. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Alessandra Gorini

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.